1- Muscle Growth and Hypertrophy Human myotube studies 4 demonstrated that IGF-1 increases fusion index, myonuclei number, and myosin heavy chain content the hallmarks of muscle hypertrophy and cellular repair
Legal Status and Future Outlook As of May 2026, Retatrutide remains investigational and is not yet FDA-approved for retail pharmaceutical distribution or general consumer use
It is foreseeable that GLP-1 weight loss drugs with superior effects and safety will become the next blockbuster
Next steps If you want to learn more about the specific clinical data behind Tonums oral approach and trial results, visit the Tonum research page to read study summaries and protocols
And a booster taken alongside a prescription GLP-1 is redundant spending, not a risk
Collectively, current evidence from RCT subgroups, observational studies, and mechanistic data supports the biological plausibility and clinical relevance of complementary cardiovascular and kidney benefits with combined SGLT2i and GLP-1RA therapy (Table 2)